Sun Pharma
PharmaIndia
0
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
0
Indications↗
Distinct diseases across all programs
0
Clinical Trials↗
All sponsored trials (all statuses)
38
Orange Book Patents
Across 4 drugs with upcoming expirations
Activity
Key Events
Details
Company Info
Regulatory
Regulatory Timeline
19882 events
FDADec 21
Cardene — CARDENE
Application NDA019488 (NDA)
FDAOct 21
Sandostatin — SANDOSTATIN
Application NDA019667 (NDA)
19922 events
FDAFeb 21
Cardene — CARDENE SR
Application NDA020005 (NDA)
FDAJan 30
Cardene — CARDENE
Application NDA019734 (NDA)
19981 event
FDANov 25
Sandostatin — SANDOSTATIN LAR
Application NDA021008 (NDA)
20061 event
FDAMay 2
Dacogen — DACOGEN
Application NDA021790 (NDA)
20081 event
FDAJul 24
Cardene — NICARDIPINE HYDROCHLORIDE
Application NDA022276 (NDA)
20091 event
FDANov 17
Cardene — NICARDIPINE HYDROCHLORIDE
Application NDA078405 (NDA)
20141 event
FDAJan 28
Dacogen — DECITABINE
Application NDA205582 (NDA)
20151 event
FDAJul 24
Odomzo — ODOMZO
Application NDA205266 (NDA)
20202 events
FDAAug 26
Winlevi — WINLEVI
Application NDA213433 (NDA)
FDAJun 26
Sandostatin — MYCAPSSA
Application NDA208232 (NDA)
20241 event
FDASep 27
Sandostatin — BYNFEZIA PEN
Application NDA213224 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)